SEC Form 4 · accession 0001618835-18-000047
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander A Fitzpatrick
Officer — General Counsel and Secretary
Period of report
Jul 2, 2018
Accepted (ET)
Jul 3, 2018 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 2, 2018 | A | 70,000 | $0.00 | A | 70,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock awards vest in two equal installments on each of October 16, 2018 and 2019 subject to Mr. Fitzpatrick's continued employment.
Remarks
The restricted stock awards were granted subject to a 90-day lock-up agreement pursuant to an Underwriting Agreement, the form of which was filed with a Registration Statement on Form S-1 as filed with the SEC on May 16, 2018. During the 90-day lock-up period commencing from May 22, 2018, the Reporting Person may not sell any vested shares.